Mitchell & Pahl Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $955K | Sell |
2,144
-5
| -0.2% | -$2.23K | 0.42% | 82 |
|
|
2025
Q1 | $1.04M | Hold |
2,149
| – | – | 0.49% | 74 |
|
|
2024
Q4 | $865K | Sell |
2,149
-30
| -1% | -$12.1K | 0.4% | 87 |
|
|
2024
Q3 | $1.01M | Sell |
2,179
-4
| -0.2% | -$1.86K | 0.47% | 82 |
|
|
2024
Q2 | $1.02M | Sell |
2,183
-29
| -1% | -$13.6K | 0.54% | 74 |
|
|
2024
Q1 | $925K | Sell |
2,212
-5
| -0.2% | -$2.09K | 0.49% | 75 |
|
|
2023
Q4 | $902K | Sell |
2,217
-13
| -0.6% | -$5.29K | 0.51% | 73 |
|
|
2023
Q3 | $775K | Sell |
2,230
-42
| -2% | -$14.6K | 0.46% | 78 |
|
|
2023
Q2 | $800K | Sell |
2,272
-1
| -0% | -$352 | 0.48% | 73 |
|
|
2023
Q1 | $716K | Sell |
2,273
-8
| -0.4% | -$2.52K | 0.45% | 81 |
|
|
2022
Q4 | $659K | Sell |
2,281
-288
| -11% | -$83.2K | 0.43% | 83 |
|
|
2022
Q3 | $744K | Sell |
2,569
-53
| -2% | -$15.3K | 0.55% | 69 |
|
|
2022
Q2 | $739K | Sell |
2,622
-155
| -6% | -$43.7K | 0.51% | 74 |
|
|
2022
Q1 | $725K | Sell |
2,777
-28
| -1% | -$7.31K | 0.46% | 78 |
|
|
2021
Q4 | $616K | Sell |
2,805
-262
| -9% | -$57.5K | 0.39% | 85 |
|
|
2021
Q3 | $556K | Sell |
3,067
-20
| -0.6% | -$3.63K | 0.4% | 82 |
|
|
2021
Q2 | $622K | Sell |
3,087
-9
| -0.3% | -$1.81K | 0.44% | 78 |
|
|
2021
Q1 | $665K | Sell |
3,096
-13
| -0.4% | -$2.79K | 0.52% | 69 |
|
|
2020
Q4 | $735K | Buy |
+3,109
| New | +$735K | 0.62% | 53 |
|